Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response-Reference-Cited by-同舟云学术

Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response

Published:2022-06 Issue:6 Volume:48 Page:1356-1361
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Barrak Dany^ORCID,Villano Anthony M.,Villafane-Ferriol Nicole,Stockton Leah G.^ORCID,Hill Maureen V.,Deng Mengying,Handorf Elizabeth A.^ORCID,Reddy Sanjay S.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference38 articles.

1. Epidemiology of pancreatic cancer;Ilic;World J Gastroenterol,2016

2. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018

3. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis;Suker;Lancet Oncol.,2016

4. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival;Rose;Ann Surg Oncol,2014

5. Better defining the role of total neoadjuvant radiation: changing paradigms in locally advanced pancreatic cancer;Vidri;Ann Surg Oncol,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.;Pancreatology;2024-09

2. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy;JAMA Network Open;2024-06-18

3. Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis;Annals of Surgical Oncology;2023-12-27

4. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer;Nature Reviews Gastroenterology & Hepatology;2023-11-30

5. Type of neoadjuvant treatment strategy is associated with differential pathologic responses in pancreatic ductal adenocarcinoma;The American Journal of Surgery;2023-11